glp 1 agonist review Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic and meta-analysis of randomized controlled trials GLP-1 receptor agonists and next-generation

Tirzepatide is available under FDA-approved prescription uses, while retatrutide is still investigational

Always consult your healthcare provider before starting, stopping, or changing any medication or supplement regimen

In these cases, diabetes occurs because the immune system attacks and gradually destroys the beta cells responsible for producing insulin

Adipose tissue reduction: Loss of intrahepatic and visceral fat with GLP-1RAs therapy is associated with decreased release of proinflammatory cytokines such as TNF-, IL-1, and IL-6 (Mehdi et al

BMC Ophthalmol

These medications mimic the hormone Glucagon-like Peptide 1 (GLP-1) which helps the pancreas release insulin in response to meals, safely lowering blood sugars